Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Scroll down to content

Posts

Posted on 7 January 20207 January 2020

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Imcivree (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
  • FDA Approves Danyelza (naxitamab-gqgk) for the Treatment of Neuroblastoma
  • FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1
  • Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

RSS Pharma Manufacturing News

  • Neurogene announces EMA grants orphan drug designation for aspartylglucosaminuria gene therapy
  • Janssen acquires rights to Hemera’s investigational eye-disorder gene therapy
  • Roche gets FDA approval of Gavreto in advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • The Prescription for a Superior Healthcare Network
  • The Actively Connected Physician: How CMS Mandated ADT Event Notifications Lead to Improved Patient Care
  • Enterprise Imaging: See What You’ve Been Missing
  • Establishing Security for Cloud Healthcare Solutions
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok